Several domestic novel coronavirus drugs have entered clinical trials

It is expected to become a "new weapon" against epidemic。

According to the scientific research group of the joint prevention and control mechanism of the State Council, China has completed phase III clinical trials of self-developed novel coronavirus drugs and is applying for conditional listing. In addition, several drugs have carried out phase III clinical trials at home and abroad, which have shown positive curative effects.

多个国产新冠药物进入临床试验

有望成抗疫“新利器”

从国务院联防联控机制科研攻关组获悉，我国已有自主研发的新冠药物完成Ⅲ期临床试验，正申请附条件上市。另有多个药物在国内外开展Ⅲ期临床试验，当前显示出积极疗效。